Atrial Fibrillation Trial, Recruiting NCT07434674 Sponsor: University of California, San Diego Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT07434674
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who already have a medical reason to have a small heart-monitoring device (called an insertable cardiac monitor) placed under their skin as part of their normal care.
  • People who are scheduled to receive, or have already received, a specific heart monitor called the Boston Scientific LUX-DX™.
  • People who have had an episode of atrial fibrillation (an irregular heart rhythm) that was detected in a hospital or urgent care setting, or during a serious illness, and who have had specific heart-tracing tests (a 12-lead ECG and at least 24 hours of heart monitoring) to confirm this.
  • People who are 18 years of age or older.
  • People who are willing and able to attend all required study visits and follow the study procedures for the full duration of the trial.
  • People (or their legal representative) who have signed and dated the study consent form.

Who may not be able to join:

  • People who have a known history of atrial fibrillation or a related heart rhythm problem (atrial flutter) before the episode that brought them into the study.
  • People who need to take heart rhythm medications for a reason other than this recent episode of atrial fibrillation.
  • People who, in their treating doctor's opinion, have a permanent medical reason that would rule out ever taking blood-thinning medication for atrial fibrillation management.
  • People who are currently enrolled in another clinical trial that could affect the results of this study.
  • People whose treating doctor has determined they have a life expectancy of less than one year.
  • People who are pregnant.
  • People who already have a medical reason to receive a different type of implanted heart device, such as a pacemaker, defibrillator, or implantable heart pressure monitor, as this could overlap with or interfere with the study device.
  • People who are unable or unwilling to follow the required study procedures.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 858-246-2016

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 November 2025
Est. completion
1 November 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Time to first documented event of AF by 12 months

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov